• Jarvis Laboratory Plymouth CMV vaccine vectors for ebola

New study shows ability of primate cytomegalovirus-based vaccine to induce high antibody levels against target pathogen in Ebola virus challenge model

 

michael jarvis plymouth

About Us

Find out more about who we are!

About Us

vaccine vectors

Our Research

Read more about our work!

Our Research

michael jarvis cmv vaccine vectors

Contact Us

We would love to hear from you!

Contact Us

The Jarvis laboratory at Plymouth University pursues the innovative design, construction and characterization of herpesvirus  cytomegalovirus CMV vaccine vectors. We apply sophisticated recombination technologies towards basic biological questions, as well as against more immediate problems concerning humanity, such as Ebola virus, HIV, Flu and other emerging infectious diseases, environmental containment of recombinant microorganisms and cancer. We work not in isolation, but instead regard our laboratory as only a single node of expertise in an international network of interactive scientists. Recombination technology – bacterial artificial chromosome BAC and CRISPR – has now reached the level whereby only our imaginations and the realities of Nature can limit what we are able to achieve.

"For a successful technology, reality must take precedence over public relations, for Nature cannot be fooled" – "You can't pitch Nature."

Richard P. Feynman. "What do you care what other people think?"